Baxter International (TICKER: BAX) Benchmark And Performance Data

there are 11 of samples in the benchmark for Baxter International in year 2022 in 2022. The total inventory for Baxter International was $3,499,000,000.00 in 2013. The total inventory for Baxter International was $2,803,000,000.00 in 2012. The total inventory for Baxter International was $2,453,000,000.00 in 2021. The total inventory for Baxter International was $1,916,000,000.00 in 2020. The total inventory for Baxter International was $1,667,000,000.00 in 2018. The total inventory for Baxter International was $1,653,000,000.00 in 2019. The total inventory for Baxter International was $1,604,000,000.00 in 2015. The total inventory for Baxter International was $1,577,000,000.00 in 2014. The total inventory for Baxter International was $1,475,000,000.00 in 2017. The total inventory for Baxter International was $1,430,000,000.00 in 2016. The sales, general, and administrative (SGA) for Baxter International was $3,315,000,000.00 in 2014. The sales, general, and administrative (SGA) for Baxter International was $3,290,000,000.00 in 2019. The sales, general, and administrative (SGA) for Baxter International was $3,283,000,000.00 in 2012. The sales, general, and administrative (SGA) for Baxter International was $3,094,000,000.00 in 2015. The sales, general, and administrative (SGA) for Baxter International was $3,084,000,000.00 in 2013. The sales, general, and administrative (SGA) for Baxter International was $2,878,000,000.00 in 2021. The sales, general, and administrative (SGA) for Baxter International was $2,746,000,000.00 in 2016. The sales, general, and administrative (SGA) for Baxter International was $2,629,000,000.00 in 2017. The sales, general, and administrative (SGA) for Baxter International was $2,621,000,000.00 in 2018. The sales, general, and administrative (SGA) for Baxter International was $2,515,000,000.00 in 2020. The sales, general, and administrative (SGA) for Baxter International was $$3,862,000,000 in 2022. The revenue volatility for Baxter International was 11.85% in 2022. The market capitalization for Baxter International was $43,058,668,339.00 in 2014. The market capitalization for Baxter International was $40,267,062,660.00 in 2013. The market capitalization for Baxter International was $40,238,340,219.00 in 2012. The market capitalization for Baxter International was $39,036,492,496.00 in 2015. The market capitalization for Baxter International was $32,359,531,317.00 in 2016. The market capitalization for Baxter International was $27,147,791,042.00 in 2017. The market capitalization for Baxter International was $25,695,035,086.00 in 2018. The market capitalization for Baxter International was $23,070,206,356.00 in 2020. The market capitalization for Baxter International was $20,516,720,125.00 in 2019. The market capitalization for Baxter International was $19,111,718,170.00 in 2021. The market capitalization for Baxter International was $$19,491,000,000 in 2022. The gross revenue for Baxter International was $9,968,000,000.00 in 2015. The gross revenue for Baxter International was $9,413,000,000.00 in 2013. The gross revenue for Baxter International was $13,936,000,000.00 in 2012. The gross revenue for Baxter International was $12,784,000,000.00 in 2021. The gross revenue for Baxter International was $11,673,000,000.00 in 2020. The gross revenue for Baxter International was $11,362,000,000.00 in 2019. The gross revenue for Baxter International was $11,099,000,000.00 in 2018. The gross revenue for Baxter International was $10,719,000,000.00 in 2014. The gross revenue for Baxter International was $10,584,000,000.00 in 2017. The gross revenue for Baxter International was $10,163,000,000.00 in 2016. The gross revenue for Baxter International was $$15,113,000,000 in 2022. The gross margin for Baxter International was $6.15% in 2022. The days sales outstanding for Baxter International was 64 days in 2022. The days payable outstanding for Baxter International was 45 days in 2022. The days of inventory for Baxter International was $97 in 2022. The cost of goods sold (COGS) for Baxter International was 64.29% in 2022. The cost of goods sold (COGS) for Baxter International was $7,679,000,000.00 in 2021. The cost of goods sold (COGS) for Baxter International was $7,086,000,000.00 in 2020. The cost of goods sold (COGS) for Baxter International was $6,802,000,000.00 in 2012. The cost of goods sold (COGS) for Baxter International was $6,601,000,000.00 in 2019. The cost of goods sold (COGS) for Baxter International was $6,340,000,000.00 in 2018. The cost of goods sold (COGS) for Baxter International was $6,138,000,000.00 in 2014. The cost of goods sold (COGS) for Baxter International was $6,110,000,000.00 in 2017. The cost of goods sold (COGS) for Baxter International was $6,047,000,000.00 in 2016. The cost of goods sold (COGS) for Baxter International was $5,822,000,000.00 in 2015. The cost of goods sold (COGS) for Baxter International was $5,251,000,000.00 in 2013. The cost of goods sold (COGS) for Baxter International was $$9,716,000,000 in 2022. The cash to cash cycle time for Baxter International was 116 in 2022. The annual percentage growth rate of Baxter International was -0.18% in 2022. Baxter International in its benchmark peer group, had rank 9 days for days sales outstanding in 2022. Baxter International in its benchmark peer group, had rank 5 for cash to cash cycle time in 2022. Baxter International in its benchmark peer group, had rank 4 days for days of inventory in 2022. Baxter International in its benchmark peer group, had rank 2 for gross revenue in 2022. Baxter International in its benchmark peer group, had rank 11 for sales growth in 2022. Baxter International in its benchmark peer group, had rank 10 for cost of goods sold as a percent of revenue in 2022. Baxter International headquarters region is Central. Baxter International has ticker symbol BAX. Baxter International has the following profile: Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.. Baxter International has primary indstury Medical Instruments & Supplies. Baxter International had a $$0 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Baxter International had AptarGroup, and Baxter International, and Dentsply Sirona, and West Pharmaceutical Services, and Intuitive Surgical, and Becton Dickinson, and Envista Holdings, and Hologic, and Cooper Cos., and Teleflex, and ResMed Inc. benchmark peer companies for its SIC code in 2022. Baxter International had 8.68% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Baxter International had 8 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Baxter International had 60,000 number of employees in 2022. Baxter International had 4.18% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Baxter International had 18.52% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Baxter International had 15 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Baxter International had 14 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Baxter International had 0.16% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Baxter International can reduce overall cost by $$2,980,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Baxter International can reduce inventory with practices including SKU Reduction in 2022. Baxter International can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Baxter International can reduce inventory with practices including Forecast Accuracy in 2022. Baxter International can reduce inventory with practices including Demand Shaping in 2022. Baxter International can reduce days sales outstanding with practices including in 2022. Baxter International can increase sales revenue by $$0 improving sales performance to next benchmark tier in 2022. Baxter International can increase revenue growth by $$24,000,000 by improving growth performance to next benchmark tier in 2022. Baxter International can increase overall revenue by $$24,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Baxter International can increase days payables outstanding with practices including Strategic Sourcing in 2022. Baxter International can increase days payables outstanding by $83,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Baxter International can improve total financial performance by $$3,997,000,000 by improving revenue, costs, and working capital in 2022. Baxter International can decrease overall working capital by $$994,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Baxter International can decrease inventory days by $580,000,000 days by reducing inventory days to next benchmark tier in 2022. Baxter International can decrease days sales outstanding by $331,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Baxter International can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Baxter International can accelerate revenue growth practices including Pricing Optimization in 2022. Baxter International can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 97 days was the measured superior or top ten performance level for cash to cash cycle time in Baxter International's peer group in 2022. 97 days was the measured advantage or top third performance level for days of inventory in Baxter International's peer group in 2022. 83 days was the measured superior or top ten performance level for days of inventory in Baxter International's peer group in 2022. 7.67% was the measured advantage or top third performance level for sales volatility in Baxter International's peer group in 2022. 6.98% was the measured superior or top ten performance level for sales volatility in Baxter International's peer group in 2022. 56 days was the measured parity or middle performance level for days sales outstanding in Baxter International's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in Baxter International's peer group in 2022. 52 days was the measured superior or top ten performance level for days sales outstanding in Baxter International's peer group in 2022. 45.77% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Baxter International's peer group in 2022. 44.22% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Baxter International's peer group in 2022. 34.38% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Baxter International's peer group in 2022. 26.35% was the measured superior or top ten performance level for gross margin in Baxter International's peer group in 2022. 125 days was the measured parity or middle performance level for cash to cash cycle time in Baxter International's peer group in 2022. 12.62% was the measured parity or middle performance level for sales volatility in Baxter International's peer group in 2022. 116 days was the measured parity or middle performance level for days of inventory in Baxter International's peer group in 2022. 101 days was the measured advantage or top third performance level for cash to cash cycle time in Baxter International's peer group in 2022. 0.07% was the measured superior or top ten performance level for sales growth in Baxter International's peer group in 2022. -0.03% was the measured parity or middle performance level for sales growth in Baxter International's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in Baxter International's peer group in 2022. $18.89% was the measured advantage or top third performance level for gross margin in Baxter International's peer group in 2022. $14.84% was the measured parity or middle performance level for gross margin in Baxter International's peer group in 2022. $$4,223,000,000 was the measured advantage or top third performance level for gross revenue in Baxter International's peer group. $$3,922,000,000 was the measured parity or middle performance level for gross revenue in Baxter International's peer group in 2022. $$15,113,000,000 was the measured superior or top ten performance level for gross revenue in Baxter International's peer group in 2022.